CARES Lumbar Artificial Disc Registry
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02139527 |
Recruitment Status :
Terminated
(Low enrollment and follow-up data on enrolled patients.)
First Posted : May 15, 2014
Last Update Posted : May 15, 2014
|
Sponsor:
DePuy Spine
Information provided by (Responsible Party):
DePuy Spine
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
The purpose of the registry is to assess outcomes following treatment with lumbar total disc replacement (TDR) in patients outside the clinical trial setting.
Condition or disease | Intervention/treatment |
---|---|
Lumbar Degenerative Disc Disease | Device: Total Disc Replacement |
Study Type : | Observational [Patient Registry] |
Actual Enrollment : | 120 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 5 Years |
Official Title: | The Centers for Arthroplasty Research and Education in Spine (CARES) Lumbar Artificial Disc Registry Protocol |
Study Start Date : | May 2007 |
Actual Primary Completion Date : | August 2009 |
Actual Study Completion Date : | August 2009 |
Resource links provided by the National Library of Medicine

MedlinePlus Genetics related topics:
Intervertebral disc disease
Intervention Details:
- Device: Total Disc Replacement
Other Names:
- CHARITE™ Artificial Disc
- PRODISC®-L Total Disc Replacement
Primary Outcome Measures :
- Change in Oswestry Disability Index (ODI) Score [ Time Frame: 3, 6, 12, 24, 36, 48, and 60 months post operative ]The ODI assesses several domains of function affected by low back pain. A change of 15 points from baseline is considered a clinical meaningful difference for the individual. The change from pre operative baseline to each follow-up assessment will be calculated.
Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Study Population
Patients that undergo lumbar total disc replacement (TDR); this includes patients treated with either the CHARITE disc or the ProDisc-L disc
Criteria
Key Inclusion Criteria:
- Treated with the lumbar TDR.
- Signed IRB approved consent document.
Key Exclusion Criteria:
- None known.
No Contacts or Locations Provided
Additional Information:
Responsible Party: | DePuy Spine |
ClinicalTrials.gov Identifier: | NCT02139527 |
Other Study ID Numbers: |
06-CAD-01 |
First Posted: | May 15, 2014 Key Record Dates |
Last Update Posted: | May 15, 2014 |
Last Verified: | May 2014 |
Keywords provided by DePuy Spine:
arthroplasty spinal CHARITE PRODISC-L |
PRODISC disc replacement lumbar |
Additional relevant MeSH terms:
Intervertebral Disc Degeneration Spinal Diseases Bone Diseases Musculoskeletal Diseases |